Key facts
- This page summarizes Bradley Allen Kreger's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 11 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 23 May 2022, 20:16.
Bradley Allen Kreger - 20 May 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Reporting relationship
- SVP, Global Operations
- Issuer ticker
- LAB
- Reported as of
- 20 May 2022
- Net transaction value
- -$29,584
- SEC form
- 4
- Accepted by SEC
- 23 May 2022, 20:16:31 UTC
- Prior SEC filing
- 24 Feb 2022
- Next SEC filing
- 20 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bradley Kreger by Nicholas Khadder, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bradley Allen Kreger filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 23 May 2022.
Change
- Previous filing in this sequence was filed on 24 Feb 2022.
- Current net transaction value: -$29,584.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,125
- Change %
- +3.4%
- Price
- $0.000000
- Shares after
- 94,433
- Date
- 20 May 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,237
- Change %
- +2.4%
- Price
- $0.000000
- Shares after
- 96,670
- Date
- 20 May 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,391
- Change %
- +2.5%
- Price
- $0.000000
- Shares after
- 99,061
- Date
- 20 May 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +25,000
- Change %
- +25%
- Price
- $0.000000
- Shares after
- 124,061
- Date
- 20 May 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +9,527
- Change %
- +7.7%
- Price
- $0.000000
- Shares after
- 133,588
- Date
- 20 May 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Tax liability
- Transaction value
- $29,584
- Shares
- -14,431
- Change %
- -11%
- Price
- $2.05
- Shares after
- 119,157
- Date
- 20 May 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,125
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,125
- Exercise price
- Footnotes
- F1, F2
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,237
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 6,711
- Date
- 20 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,237
- Exercise price
- Footnotes
- F1, F3
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,391
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 16,735
- Date
- 20 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,391
- Exercise price
- Footnotes
- F1, F4
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -25,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 20 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F1, F5
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -9,527
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 28,584
- Date
- 20 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,527
- Exercise price
- Footnotes
- F1, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
Footnote F2
On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.
Footnote F3
On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
Footnote F4
On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
Footnote F5
On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.
Footnote F6
On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.